In our cross-sectional analysis of CPHIV who did or did not meet clinical definitions of “possible” mitochondrial disease, we found significantly higher plasma levels of the mitokines FGF21 and/or GDF15 in those with MDC score ≥3. Here, GDF15 is linked to mitochondrial disease.